Grade: Pharmaceutical Grade
Factory Location: Xiamen, Fujian
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Monthly Production Capacity: 1000kg
Packaging Information: 25kg/drum 1kg/bottle
Delivery Lead Time: 7 days after payment
Sample Provided: yes
Payment Terms: L/L
Product name |
Octadecanedioic acid; 1,16-Dicarboxyhexadecane; 1,16-Hexadecanedicarboxylic acid; 1,18-Octadecanedioic acid; Emerox 118; Semaglutide intermediate |
CAS No. |
871-70-5 |
Molecular Formula |
C18H34O4 |
Molecular Weight |
314.466 |
Molecular Structure |
![]() |
Quality Standard |
98% up by HPLC |
Appearance |
White or off-white powder |
|
ANALYSIS |
SPECIFICATION |
RESULTS |
Appearance |
White or off-white powder |
Conforms |
DC16 |
< 0.2% |
0.12% |
DC20 |
< 0.2% |
ND |
Purity (by HPLC) |
≥ 98.0% |
99.6% |
Conclusion |
The product meets enterprise standard CDMO service: We can customized manufacturing according to your requirement. |
|
What is Octadecanedioic acid?
Octadecanedioic acid is one of key intermediates of Semaglutide. Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control. Side effects include nausea, vomiting, diarrhea, abdominal pain, and constipation.